PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Beneficial effects of bardoxolone methyl, an Nrf2 activator, on crush-related acute kidney injury in rats.

Rat / Crush

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31471671 ↗2019Reported benefit

Beneficial effects of bardoxolone methyl, an Nrf2 activator, on crush-related acute kidney injury in rats.

RatCrushLimb / muscle crushWistarMalen = 64 rats in 8 groups, n = 8 per groupIntraperitoneal10 mg/kg

Model: Crush syndrome induced by 6 h of direct compression of both hind limbs with 3.6 kg blocks per side, followed by 3 or 24 h decompression

Bardoxolone methyl reduced renal KIM-1, NGAL, TNF-alpha, TGF-beta1 and total oxidant status and increased total antioxidant status at 3 and 24 h after decompression, lowered serum creatine kinase, blood urea nitrogen and creatinine, and decreased apoptosis.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.